About this document
Rofecoxib Withdrawal: Lessons Learned by kharainyoo is a document available to read on EtoBox.
The document discusses the withdrawal of the drug rofecoxib (Vioxx) and highlights the need for greater transparency from pharmaceutical companies regarding adverse events prior to drug licensing. It emphasizes the importance of rigorous clinical trials and systematic reviews to ensure drug safety and prevent similar issues in the future. Recommendations include legal requirements for disclosure of clinical trial data and phased introduction of new drugs through independent trials.
- Author
- kharainyoo
- Language
- EN